Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9670480 | 0.85 | MAPT (0.58) | TSHRMAPK1TDP1L3MBTL1KMT2A | |
| SCHEMBL481007 | 0.83 | MAPK1 (0.48) | TSHRMAPK1TDP1L3MBTL1MAPT | |
| SCHEMBL24264721 | 0.83 | KMT2A (0.48) | TSHRMAPK1TDP1L3MBTL1KMT2A | |
| SCHEMBL11638729 | 0.83 | MAPK1 (0.61) | TSHRMAPK1TDP1L3MBTL1KMT2A | |
| SCHEMBL5635245 | 0.80 | L3MBTL1 (0.43) | TSHRMAPK1TDP1L3MBTL1KMT2A | |
| SCHEMBL23578233 | 0.80 | TSHR (0.45) | TSHRMAPK1TDP1L3MBTL1KMT2A | |
| SCHEMBL20900122 | 0.79 | L3MBTL1 (0.46) | TSHRMAPK1TDP1L3MBTL1KMT2A | |
| SCHEMBL23588090 | 0.78 | TSHR (0.72) | TSHRMAPK1TDP1POLBMAPT | |
| SCHEMBL101986 | 0.77 | L3MBTL1 (0.41) | TSHRMAPK1TDP1L3MBTL1KMT2A | |
| SCHEMBL23239259 | 0.77 | TRPA1 (0.45) | L3MBTL1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080255202-A1 | Phenylthioacetic Acid Derivatives and Use Thereof | BAYER HEALTHCARE AG (DE) | 2008-10-16 | — | — | US | disclosed |
| US-20080255202-A1 | Phenylthioacetic Acid Derivatives and Use Thereof | BAYER HEALTHCARE AG (DE) | 2008-10-16 | — | — | US | disclosed |
| US-20080255202-A1 | Phenylthioacetic Acid Derivatives and Use Thereof | BAYER HEALTHCARE AG (DE) | 2008-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255202-A1 | Phenylthioacetic Acid Derivatives and Use Thereof | PAH, TST, MPST | TSHR 1964/4885MAPK1 1814/4885TDP1 347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.